FDA Vaccine Advisers Will Review Pfizer’s COVID-19 Vaccine Dec. 10

FDA’s vaccine advisory committee will meet on Dec. 10 to discuss Pfizer and BioNTech’s COVID-19 vaccine, the agency announced Friday (Nov. 20), the same day the companies submitted an emergency use authorization request for their vaccine. Pfizer and BioNTech submitted an EUA request for their mRNA COVID-19 vaccine just two days after Pfizer announced the vaccine had demonstrated 95% efficacy in a final phase 3 study analysis. In their Friday press release, the companies said they look forward to FDA’s...